Lauren Lamendola, PA
Medical · Mount Pleasant, SCNPI 1134726052
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 62.3% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $4,338 and has fallen 98.9% since, to $49 in 2025.
Across 54 payments — averaging $84.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Peerless Surgical Inc.$869
- Stryker$149
- Johnson & Johnson$99
- Novo Nordisk$98
- Biohaven Pharmaceuticals, Inc.$59
- plus $443 from 16 others
What the payments were for
- Travel & lodging$93921%
- Food & beverage$1,21227%
- Education$2,40053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $2,834 |
| Peerless Surgical Inc. | 6 | $869 |
| Stryker | 1 | $149 |
| Johnson & Johnson(2 entities) | 5 | $99 |
| Novo Nordisk | 5 | $98 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Boehringer Ingelheim | 2 | $35 |
| Almatica Pharma LLC | 2 | $34 |
| Pfizer | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $29 |
| Mylan Specialty L.p. | 1 | $29 |
| AbbVie | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| AstraZeneca | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$149
How this compares
$4,551 in reported general payments places this provider in the 85th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $223 |
| Oxycodone Hcl | 24 | $133 |
| Methylprednisolone | 20 | $131 |
| Meloxicam | 21 | $85 |
| Ciprofloxacin Hcl | 19 | $59 |
| Tramadol Hcl | 16 | $48 |
| Cyclobenzaprine Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other medical in Mount Pleasant
- Ryan TroutMount Pleasant$11K
- Sarette KelleyMount Pleasant$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
- Cameron PappasGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.